tirzepatide weight loss program michigan Wegovy vs. Zepbound: Which Virtual is Right for You? Semaglutide & Tirzepatide for Weight

doi:10.1136/heartjnl-2021-319596

GHK-Cu is not FDA approved as a drug for skin repair, anti-aging, injection, or any therapeutic use, and researchers exploring administration should review our guide on where to inject GHK-Cu for the practical considerations

Unlike oral supplements that lose potency through stomach acid and intestinal processing, intramuscular delivery achieves significantly higher bioavailability

BMJ 335 , 1134 (2007)

The study found that overweight or obese individuals undergoing tirzepatide treatment had a higher probability of achieving equal to or greater than 5%, 10%, and 15% weight loss at three, six, and 12 months, respectively, as compared to individuals who were getting treated with semaglutide